CAB39 and glioma: Furthermore, it promotes cancer cell metastasis via miR-451 and suppresses glioma cell proliferation and invasion in vitro and in vivo via suppression of the mTOR/HIF−1α/VEGF signaling pathway by targeting CAB39 [65].